- Report
- October 2024
- 191 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- March 2025
- 186 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- July 2024
- 170 Pages
Global
From €5339EUR$5,950USD£4,595GBP
- Report
- April 2025
- 739 Pages
Global
From €5249EUR$5,850USD£4,518GBP
- Report
- April 2025
- 168 Pages
Global
From €5249EUR$5,850USD£4,518GBP
- Report
- April 2025
- 307 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- March 2025
- 175 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- July 2024
- 105 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- July 2024
- 100 Pages
Global
From €3365EUR$3,750USD£2,896GBP
- Report
- November 2024
- 150 Pages
Global
From €4352EUR$4,850USD£3,746GBP
- Report
- May 2024
- 200 Pages
Global
From €3724EUR$4,150USD£3,205GBP
- Report
- May 2023
- 150 Pages
Global
From €5339EUR$5,950USD£4,595GBP
- Report
- October 2022
- 118 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- February 2024
- 119 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- June 2022
- 112 Pages
Global
From €4262EUR$4,750USD£3,668GBP

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases.
Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more